Welcome to Boston Biomedical Inc. (BBI)

09.03.2010

19 April, 2010
First-In-Class Drug BBI608 Tested in Patients with Advanced Cancer

3 December, 2008
Next Generation RNAi Technology Discovered by AiRNA Pharmaceuticals and Boston Biomedical Published in Nature Biotechnology

29 January, 2007
BBI opens its door with a $5.0 million research agreement with its parent ArQule Inc.

16 Febuary, 2007
Dr. Chiang Li, founder, chairman and CEO of BBI, speaks on the formation of BBI to Boston Business Journal

Brief Introduction

Boston Biomedical, Inc. is a privately held biotechnology company focusing on research and development of novel therapeutics to treat cancer.

|||||||